Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Increased CDRH Post-Approval Vigilance Plays Out In Medtronic X-Stop Trials

Jan 28 2008

Related Content

Medtronic Taps Into Expanded Spinal Market With $3.9 Billion Kyphon Deal

Jul 30 2007

St. Francis’ X-Stop Gets FDA Green Light To Treat Lumbar Spinal Stenosis

Nov 28 2005

More from Archive

More from Medtech Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window